Recherche :
Recherche avancée
Références d'articles
Rofecoxib and ealy relapse of inflammatory bowel disease : an open-label trial.
[Auteurs : BIANCONE L, TOSTI C, GEREMIA A, FINA D, PETRUZZIELO C, EMERENZIANI S, PALLONE F]
An open-label trial of the selective cyclo-oxygenase-inhibitor, rofecoxib, in inflammatory bowel disease-associated periperical arthritis and arthralgias.
[Auteurs : REINISCH W, MIEHSLER W, DEJACO C, HARRER M, WALDHOER T, LICHTENBERGER C, VOGELSANG H]
Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
[Auteurs : SUMMERS RW, ELLIOTT DE, QADIR K, URBAN JF, THOMPSON R, WEINSTOCK JV]
Aminosalicylates and Colorectal Cancer in IBD: A Not-So Bitter Pill to Swallow
[Auteurs : RYAN BM, RUSSEL MG, LANGHOLZ E, STOCKBRUGGER RW]
5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study
[Auteurs : VAN STAA TP, CARD TR, LEUFKENS HGM, LOGAN RFA]
The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease.
[Auteurs : KANE SV, LEMIEUX N]
Antibiotic use and the risk of flare of inflammatory bowel disease.
[Auteurs : ABERRA fn, BRENSINGER C, BILKER WB, LICHTENSTEIN GR, LEWIS JD]
Risk factors for inflammatory bowel disease in the general population.
[Auteurs : GARCIA RODRIGUEZ LA, GONZALEZ-PEREZ A, JOHANSSON S, WALLENDER MA]
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.
[Auteurs : KANDIEL A, FRASER AG, KORELITZ BI, BRENSINGER C, LEWIS JD]
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study.
[Auteurs : JÄRNEROT G, HERTERVIG E, FRIIS-LIBY I, BLOMQUIST L, KARLEN P, GRÄNNÖ C, VILIEN M, DANIELSSON A, VERBANN H, HELLSTRÖM PM, MAGNUSON A, CUMAN B]
Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease—A Randomized, Controlled, Open-Label, Multicenter Stud
[Auteurs : SCHRÖDER O, MICKISCH O, SEIDLER U, DE WEERTH A, DIGNASS A, HERFARTH H, REINSHAGEN M, SCHREIBER S, JUNGE U, SCHROTT M, STEIN J]
Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial.
[Auteurs : DE SILVA AD, TSIRONI E, FEAKINS RM, RAMPTON DS]
Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease.
[Auteurs : BASTIDA G, NOS P, AGUAS M, BELTRAN B, RUBIN A, DASI F, PONCE J]
Colorectal Cancer Prognosis Among Patients With Inflammatory Bowel Disease
[Auteurs : DELAUNOIT T, LIMBURG PJ, GOLDBERG RM, LYMP JF, LOFTUS Ev Jr]
Live events and inflammatory bowel disease relapse: a prospective study of patients enrolled in remission.
[Auteurs : VIDAL A, GOMEZ-GIL E, SANS M, PORTELLA MJ, SALAMERO M, PIQUÉ JM, PANES J]
Capsule involvement versus enteroclys in the detection of small-bowel involvement in Crohn’s disease: A prospective trial.
[Auteurs : MARMO R, ROTONDANO G, PISCOPO R, BIANCO MA, SIANI A, CATALANO O, CIPOLETA L]
Geographical Variations of Inflammatory Bowel Disease in France: A Study Based on National Health Insurance Data.
[Auteurs : NERICH V, MONNET E, ETIENNE A, SAMY L, RAMEE C, WEILL A, VALLIER N, VANBOCKSTAEL V, AULELEY GR, ALLEMAND H, CARBONNEL F]
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind placebo-controlled trial.
[Auteurs : BROOKLYN TN, DUNNILL GS, SHETY A, BOWDEN JJ, WILIAMS JDL, GRIFFITHS EM, FORBES AEM, GREENWOOD R, PROBERT CS]
Review article: helminths as therapeutic agents for inflammatory bowel disease.
[Auteurs : HUNTER MM, MCKAY DM]
Mesalamine-Related Lung Disease: Clinical, Radiographic, and Pathologic Manifestations.
[Auteurs : FOSTER RA, ZANDER DS, MERGO PJ, VALENTINE JF]
Appendectomy and subsequent risk of inflammatory bowel diseases.
[Auteurs : FRISCH M, JOHANSEN C, MELLEMKJAER L]
The SIBDQ: further validation in ulcerative colitis patients
[Auteurs : HAN SW, GREGORY W, NYLANDER D]
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
[Auteurs : FRASER AG, ORCHARD TR, JEWELL D]
Cancer risk in patients with inflammatory bowel disease: a population-based study
[Auteurs : BERNSTEIN CN, BLANCHARD JF, KLIEWER E]
Inflammatory bowel disease is not associated with an increased risk of lymphoma
[Auteurs : LEWIS JD, BILKER WB, BRENSINGER C]
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
[Auteurs : LOWRY PW, FRANKLIN CL, WEAVER AL ]
Therapy of inflammatory bowel disease
[Auteurs : SANDS BE]
Smoking and inflammatory bowel disease
[Auteurs : RUBIN DT, HANAUER SB]
Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
[Auteurs : LOWRY PW, FRANKLIN CL, WEAVER AL ]
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study
[Auteurs : FAUBION W, LOFTUS EV, HARMSEN WS]
Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease
[Auteurs : CUFFARI C, HUNT S, BAYLESS T]
The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease
[Auteurs : KLOTZ U]
Pancréatites aiguës induites par les médicaments dérivé de l'acide 5-aminosalicylic : rapport de cas et examen de la littérature
[Auteurs : DECOCQ G, GRAS-CHAMPEL V, VROLANT-MILLE C]
Bone mineral density in patients with recently diagnosed inflammatory bowel disease
[Auteurs : SCHOON EJ, BLOK BM, GEERLING BJ]
Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease
[Auteurs : ORCHARD TR, THIYAGARAJA S, WELSH KI ]
Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology
[Auteurs : SCOTT EM, GAYWOOD I, SCOTT BB]
Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study.
[Auteurs : NORGARD B, FONAGER K, PEDERSON L, JACOBSEN BA, SORENSEN HT ]
Stem cell transplantation for inflammatory bowel disease: practical and ethical issues
[Auteurs : HAWKEY CJ, SNOWDEN JA, LOBO A]
Coût de la première prise en charge des maladies inflammatoires chroniques intestinales
[Auteurs : ROLLAND N, GRANDBASTIEN B, MERLE V]
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis
[Auteurs : STOKKERS PC, REITSMA PH, TYTGAT GN]
Pronostic de la grossesse au cours des maladies inflammatoires chroniques intestinales
[Auteurs : TENNENBAUM R, MARTEAU P, ELEFANT E]
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease
[Auteurs : LESAGE S, ZOUALI H, CEZARD JP]
Epidemiology of inflammatory bowel diseases in the elderly in the province of Liege
[Auteurs : PIRONT P, LOUIS E, LATOUR P]
Inflammatory bowel disease
[Auteurs : PODOLSKY DK]
Laparoscopic surgery for inflammatory bowel disease: results of the past decade
[Auteurs : GURLAND BH, WEXNER SD]
Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease
[Auteurs : LAMERS CB, GRIFFIOEN G, VAN HOGEZAND RA]
Inflammatory bowel disease
[Auteurs : SCHOLMERICH J]
Valeur diagnostique de l'échographie de haute fréquence dans la maladie de Crohn et cancers coliques
[Auteurs : REIMUND JM, JUNG-CHAIGNEAU E, CHAMOUARD P]
Why children with inflammatory bowel disease are diagnosed at a younger age than their affected parent
[Auteurs : LEE JC, MCGREGOR C, MACPHERSON AJ]
Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study
[Auteurs : DUGGAN AE, USMANI I, NEAL KR]
Maladies inflammatoires chroniques intestinales et grossesse. Etude de cas
[Auteurs : LARZILLIERE I, BEAU P]
Inflammatory Bowel Disease
[Auteurs : LICHTENSTEIN GR]
Rectal endosonography in inflammatory bowel disease: differential diagnosis and prediction of remission
[Auteurs : GAST P, BELAICHE J]
Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A Danish 16-year nationwide follow-up study
[Auteurs : RASMUSSEN HH, FONAGER K, SORENSEN HT ]
The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls
[Auteurs : SCHULTSZ C, VAN DEN BERG FM, TEN KATE FW]
Transrectal ultrasound in the diagnosis and management of inflammatory bowel disease
[Auteurs : DAGLI U, OVER H, TEZEL A]
Biologics in inflammatory bowel disease: how much progress have we made ?
[Auteurs : FAUBION W, SANDBORN WJ]
Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease.
[Auteurs : WRIGHT S, SANDERS DS, LOBO A, LENNARD L]